title: What's new in antibiotics?
abstract: Antibiotics are important agents in dermatologic practice. New drugs have expanded the therapeutic approach to uncomplicated skin infections and complicated infections involving deeper soft tissue or infections that require surgical intervention. This article reviews new antibiotics of dermatologic importance, including daptomycin (cyclic lipopeptide), linezolid (oxazolidinone), quinupristin-dalfopristin (streptogramins), moxifloxacin and gatifloxacin (fluoroquinolones), and dalbavancin and oritavancin, which are presently under investigation.
authors.affiliation: Department of Infectious Diseases, Cleveland Clinic Foundation, OH 44195, USA. padmanr@ccf.org
authors.forename: Ravindran A
authors.initials: RA
authors.lastname: Padmanabhan
authors.forename: Steven P
authors.initials: SP
authors.lastname: Larosa
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Tomecki
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents